Cargando…
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520256/ https://www.ncbi.nlm.nih.gov/pubmed/34654425 http://dx.doi.org/10.1186/s12943-021-01437-0 |
| _version_ | 1784584631886020608 |
|---|---|
| author | Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J. Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar |
| author_facet | Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J. Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar |
| author_sort | Kizhakeyil, Atish |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8520256 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85202562021-10-20 DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J. Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar Mol Cancer Letter to the Editor BioMed Central 2021-10-16 /pmc/articles/PMC8520256/ /pubmed/34654425 http://dx.doi.org/10.1186/s12943-021-01437-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter to the Editor Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J. Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_full | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_fullStr | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_full_unstemmed | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_short | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes |
| title_sort | ddx3x loss is an adverse prognostic marker in diffuse large b-cell lymphoma and is associated with chemoresistance in aggressive non-hodgkin lymphoma subtypes |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520256/ https://www.ncbi.nlm.nih.gov/pubmed/34654425 http://dx.doi.org/10.1186/s12943-021-01437-0 |
| work_keys_str_mv | AT kizhakeyilatish ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT zaininurmahirahbintemohammed ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT pohzhisheng ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT wongbrandonhansiang ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT lohxinpeng ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT ngaikseng ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT lowzunsiong ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT prasannanpraseetha ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT gongchun ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT tanmichelleguetkhim ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT nagarajanchandramouli ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT huangdachuan ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT lupangwan ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT limjingquan ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT barranssharon ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT ongchoonkiat ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT limsoonthye ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT chngweejoo ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT followsgeorge ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT hodsondanielj ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT dumingqing ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT gohyeowtee ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT tansuathoon ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT grigoropoulosnicholasfrancis ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes AT vermanavinkumar ddx3xlossisanadverseprognosticmarkerindiffuselargebcelllymphomaandisassociatedwithchemoresistanceinaggressivenonhodgkinlymphomasubtypes |